🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

RecruitingNAAges any - anyAllM.D. Anderson Cancer Center
NCT02438904 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1\) Patients who have poor or no graft function post stem cell transplantation. Exclusion Criteria: N/A
💊

What it tests

  • CD34 Positive Stem Cell Infusion
  • Miltenyi device
📍

Where

1 site
University of Texas MD Anderson Cancer Center
Houston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy